Results 31 to 40 of about 459,727 (225)

Impact of COVID-19 pandemic on vaccination against meningococcal C infection in Brazil

open access: yesVaccine: X, 2022
Objective: Analyzing the impact of COVID-19 pandemic on meningococcal C conjugate vaccination in Brazil. Methods: Ecological study, based on interrupted time series, carried out with data collected through the Information System of the National ...
Thales Philipe Rodrigues da Silva   +7 more
doaj   +1 more source

Relative contributions of parental intention and provider recommendation style to HPV and meningococcal vaccine receipt

open access: yesHuman Vaccines & Immunotherapeutics, 2019
We described the relative contributions of parental intention and provider recommendation style to HPV and meningococcal vaccine receipt. Parent-child dyads that were eligible for both meningococcal and HPV vaccines participated in pre-visit surveys and ...
Terresa J. Eun   +6 more
doaj   +1 more source

Meningococcal vaccination in pregnancy [PDF]

open access: yesHuman Vaccines & Immunotherapeutics, 2018
Invasive meningococcal disease causes meningitis and septicemia worldwide with highest rates of disease occurring in children
Bahaa Abu Raya, Manish Sadarangani
openaire   +3 more sources

Lower incidence and higher case fatality rates associated with invasive meningococcal disease during COVID-19 pandemic restrictions (March 2020 to July 2021) in England

open access: yesInternational Journal of Infectious Diseases
Objectives: Invasive meningococcal disease (IMD) declined during lockdown periods, whereas case fatality rates (CFRs) increased. These returned to baseline when restrictions were removed and IMD was re-established.
Emma J. Heymer   +7 more
doaj   +1 more source

Meningococcal vaccine evolution

open access: yesClinical Management Issues, 2012
Neisseria meningitidis is a leading cause of bacterial sepsis and meningitis worldwide. Although polysaccharide and glycoconjugate vaccines have been developed for serogroups A, C, Y and W-135, currently there are no broadly effective vaccines available for the prevention of meningococcal B disease.
BONA, Gianni, Guidi C.
openaire   +7 more sources

Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease

open access: yesCanada Communicable Disease Report, 2020
Background: Trumenba™, a bivalent, factor-H binding protein meningococcal serogroup B (MenB-fHBP) vaccine was authorized for use in Canada in October 2017 for the prevention of invasive meningococcal disease (IMD) caused by Neisseria meningitidis ...
Robyn Harrison   +3 more
doaj   +1 more source

Vaccination for girls and women across the life course: Evidence‐based recommendations for clinical practice and policy

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Vaccination across the life course is a cornerstone of preventive health care for girls and women. Although WHO recommends completion of essential vaccines by adolescence, global coverage remains suboptimal. Vaccine‐preventable diseases—including HPV‐related cancers, vaginal, vulvar, anal, oropharyngeal, influenza, pertussis, hepatitis B ...
Hema Divakar   +13 more
wiley   +1 more source

Optimizing timing of adolescent vaccines: Impact of initiating HPV vaccination before Tdap or meningococcal vaccination on timely completion of the HPV vaccine series

open access: yesHuman Vaccines & Immunotherapeutics, 2023
To explore the impact on timely series completion of initiating the HPV vaccine series prior to other vaccines in the adolescent platform (Tdap or meningococcal vacccines), we created a cohort of children aged 9 in 2015 who were continuously enrolled ...
Sidika Kajtezovic   +4 more
doaj   +1 more source

Trends in hospitalizations for vaccine‐preventable diseases in the United States from 2014 to 2024

open access: yesJournal of Hospital Medicine, EarlyView.
Abstract Background and Objectives Vaccination rates have declined in recent years, resulting in outbreaks of vaccine‐preventable diseases (VPDs) among children. We aimed to evaluate VPD hospitalization rates from 2014 to 2024 and to report associated trends in outcomes including intensive care utilization, mortality, readmissions, and costs.
Nathan M. Money   +5 more
wiley   +1 more source

Explosive Weapons Trauma Care Collective (EXTRACCT) Blast Injury Clinical Practice Guideline: Abdominal Blast Injuries

open access: yesWorld Journal of Surgery, EarlyView.
This guideline from the Explosive Weapons Trauma Care Collective (EXTRACCT) outlines best practices for managing abdominal blast injuries in resource‐limited environments, especially after blast injuries from explosive ordnance including improvised explosive devices.
Sara Barbara Anna Morel   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy